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Amino acid sequence analysis was carried out on the so-called 'insoluble
tryptic　 peptide(αT12,13)'which　 was　 precipitated　 when　 the　 tryptic　 hydro-
lysate　 of　the　 α-polypeptide　 chain　 in　macaca　 mulatta　 monkey　 hemoglobin　 was
adjusted to pH 6.4. This peptide was oxidized with performic acid and then 
was hydrolyzed with chymotrypsin. The chymotryptic hydrolysate was 
isolated by column chromatography, purified by paper chromatography, 
and amino acid compositions of the peptides in the hydrolysate were analy-
zed. Amino acid sequences of these chymotryptic peptides were determined 
by the DNP and PTC methods and the partial hydrolysis. In addition, the
oxidized　 insoluble　 tryptic　 peptide　 was　 rehydrolyzed　 in　1N　 NH4OH　 at 0℃
with trypsin for 7 hours. Amino acid compositions and N-terminal amino 
acid residues of the peptides isolated and purified by column and paper ch-
romatographies were examined. By considering these results together, the
amino　 acid　 sequence　 of　 the　 insoluble　 tryptic　 peptide(αT12,13)was　 deter-
mined. It was compared with the known sequence of human hemoglobin.
                  INTRODUCTION 
   A protein from a certain living organism has its own peculiar stru-
cture, and therefore it is a matter of course that not only its amino 
acid composition but its sequence is strictly definite. It is because 
biosynthesis of proteins is under the strict genetic control, and so a 
difference in a gene results in a difference in a protein molecule. It is 
natural that the structures and the properties of proteins are slightly 
different among the species whose origins were different, even if the 
proteins have the same name and similar functions. It is, what is called, 
species specificities of proteins, and investigations on this matter will 
surely give much valuable information to evolutional problems of living 
organisms.
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   Since hemoglobin has the structure similar to all animals, comp-
arative biochemical studies on how the molecular structures of hemo-
globins from various species have changed in the evolutional process 
are of interest as much as the elucidation of the correlation between 
their structures and functions. In addition, hemoglobins are one of 
good materials because they widely distribute in the animal kingdom 
and because they are isolated and purified relatively more easily than 
other proteins. The whole primary structure of human hemoglobin was 
first determined 31 and snccessively horse hemoglobin was studied'91 
Besides, the primary structures of hemoglobins of bovine 231, sheep2', 
lama', piggy', rabbit", carp`", gorilla31, lemur fulvus7', camel", and 
so forth are being investigated. 
   According to MATSUDA et al."", the a-polypeptide chain of horse 
hemoglobin is composed of 141 amino acid residues just like that of 
human hemoglobin, and between both there are 17 amino acid exchan-
ges. Similary, there are 12 exchanges between the primary structures 
of human cytochrome C22' and horse cytochrome C111, both of which 
have already been determined to be composed of 104 amino acid 
residues. The above examples on hemoglbin and cytochrome C appear 
to show that the molecular evolution rate of these proteins are nearly 
the same as each other. However, further investigation will be requi-
red in order to confirm the relation between the evolution of living 
organisms and the molecular evolution of proteins which compose the 
organisms themselves. At this stage, however, it can be readily red-
uced that the proteins, for instance, the primary structures of hemo-
globins, from the two species of organisms which are more closely 
related in the evolutional process have greater similarity than those 
from the species which are remote. In fact, according to reports so far 
published, these assumptions are fully expected. A lot of investigations 
concerning the differences between human and nacaca niulatta monkey 
hemoglobins have been performed immunologically, or by using as paper 
chromatography and agar gel electrophoresis. Most reports demonst-
rated the resemblance between them. In this laboratory, SHIKAYA25> 
pointed out the similarity by the finger printing and MATSUDA and 
MAITA20), by the determination of the N-terminal amino acid residue. 
Concerning the primary structure TAKEI27' and MAITA171 reported that 
the amino acid compositions of the tryptic peptides soluble at pH 
6.4 have four differences in the three peptides from the a-polypetide 
chain and six differences in the five peptides from the ~-polypeptide 
chain. The present author determined the amino acid composition and 
sequence of the tryptic peptide insoluble at pH 6.4 in the a-polypeptide 
chain of macaca mulatta monkey hemoglobin. 
             MATERIALS AND METHODS 
1) Preparation of the Insoluble Tyyptic Peptide (aT12, 13)
    Hemoglobin was prepared by DRABBRIN's method") from blood obta-
ined from the abdominal aorta of an adult macaca mulatta monkey. By 
TEAL'S method 28 , the heme was removed to get globin, which was 
separated into a and Q-polypeptide chains by the countercurrent distri-
bution method21 with the solvent system of sec. -butanol containing 
0.08% trichloroacetic acid, propionic acid, and water (8.7:1.5:11.0). 
The a-polypeptide chain (3g) was hydrolyzed at pH 8.0 for 4 hours at 
37°C with 30mg of trypsin which was prepared by inactivating chymo-
trypsin. when this hydrolysate was adjusted to pH 6.4, the so-called 
insoluble tryptic peptide was precipitated. The precipitate was obta-
ined by centrifugation (3,000 r . p . m, 20 min.). 
2) Oxidation of the Insoluble Tryptic Peptide (aT12, 13),with Performic 
   Acid 
   The insoluble tryptic peptide (aT12,13) was oxidized with performic 
acid according to HIRS' method.") To 9ml of 99% formic acid, lml of 30% 
H2 02 was mixed, immediately sealed perfectly, and allowed to stand 
for 2 hours at room temperature (250C). After that, the solution was 
kept at 0°C for 30 minutes. On the other hand, 300mg of the insoluble 
tryptic peptide (aT12, 13) was dissolved in 5ml of 99% performic acid 
and was mixed with the above-described solution. The mixture was 
allowed to stand at 0°C for 3 hours. After the reaction was stopped, 
the reaction mixture was added deionized water so that its volume 
became 100ml. It was dried under reduced pressure by a rotary eva-
porator in order to remove performic acid. 
   3) Digestion of the Oxidized Insoluble Tryptic Peptide (aT12, 13) 
with Chymotrypsin 
   300mg of the insoluble tryptic peptide ((.T12, 13) oxidized with 
performic acid was dissolved in 15m1 of deionized water and denatured 
in 95°C hot water for 5 minutes. After cooling, the pH was brought to 10.0 
with O.1N NaOH and the solution was shaken for 30 minutes. To this 
was added 9mg of chymotrypsin, and the mixture was hydrolyzed at 37°C 
for 4 hours. The pH of the hydrolysate was measured every hour and 
kept to be 9.0 by the addition of 0.1N NaOH. During the hydrolysis 
37°C was maintained by means of a circulating constant temperature 
bath. After the digestion, the h~drolysate was dried under reduced 
pressure below pH 6.0. 
4) Redigestion of the Oxidized Insoluble Tryptic Peptide (aT12, 13) 
 with Trypsin 
   In 5m1 of IN NH_, OH, 100mg of the performic acid-oxidized inso-
luble tryptic peptide (uT12, 13) was dissolved and adjusted to pH 8,0
with 0.1N acetic acid. To this was added 3mg of trypsin prepared by 
the inactivation of chymotrypsin. Hydrolysis was carried out at 0°C for 
7 hours. The pH of the hydrolysate was measured every hour and 
maintained at 8.0 by adding 0.1N NH4OH. After the digestion, the 
hydrolysate was dried under reduced pressure' below pH 6.0 in order 
to remove ammonia. 
5) Digestion of the Chymotryptic Peptide with Pepsin 
    Long peptides in the chymotryptic digest were necessary to be 
further hydrolyzed with pepsin into shorter peptides. About 2'Umoles of 
a peptide was dissolved in 2m1 of 0.01N HC1 and to this was added 
2mg of pepsin which was dissolved in 0.05N HCl. After shaken well, 
the solution was adjusted to pH 2.0 with O.IN HC1 and then hydrolyzed 
at 37°C for 3 hours. The hydrolysate dissolved in deionized water was 
dried under reduced pressure. 
6) Column Chromatography of Peptides on Dowex 1x2 
   The resin (Dowex 1x2), after washed with 1N NH4OH, water, 
glacial acetic acid, and water successively to be acetic acid type and 
evacuated, was placed in a column (2 x 150cm) which was warmed at 
37°C. The column was thoroughly equilibrated with the starting buffer, 
pH 8.5, the mixture of 1% picoline, 1% pyridine, and 1% 2.4 lutidine. 
The chymotryptic hydrolysate of the insoluble tryptic peptide (rIT12, 
13) dissolved in 10m1 of deionized water and adjusted to pH 9.0 was 
put on the column. The elution was carried out at a flow rate of 200 ml 
per hour until the fraction No. 35 with the above-described starting 
buffer, and after that the gradient elution was employed; Gradient 
I was performed from the fraction No. 36 by supplying 0.05N acetic 
acid solution in the upper chamber to 1 L of the starting buffer in 
the mixing chamber; similarly, Gradient II was done from the fraction 
No. 151 by supplying 1N acetic acid solution. The eluate was colle-
cted into 15 ml-fractions by a fraction collector. A 0.3 m1 portion 
of each fraction, after alkali hydrolysis,' was subjected to ninhydrin 
color reaction according to YEMM and COCKING' s metbod80' . The ninhydrin-
positive fractions were fractionally combined and dried under reduced 
pressure below 37°C. 
   The tryptic hydrolysate in 1N NH, OH was also isolated by column 
chromatography. The resin (Dowex 1x2), the acetic acid type, was 
placed in a column (0.9 x 60cm) after evacuation. First 20 fractions were 
eluted with starting buffer pH 8.5, acetate buffer, the mixture of 1% 
picoline and 4% pyridine. From the fraction No. 21 Gradient I was 
employed with the acetate buffer pH 5.0 of 4% pyridine; from the 
fraction No. 45, Gradient II, with 1N acetic acid. The flow rate was 
150m1 per hour. The eluate was colored by ninhydrin reagent, and
the positive fractions were collected and dried under reduced pressure. 
   7) Identification of Peptides by Paper Chromatography 
   Each dried peptide was dissolved in 3ml of deionized water and a 
small portion of this solution was applied on a sheet of Toyo filter 
paper, No. 50. Development was carried out in the constant temper-
ature room at 24-25°C by using the descending method with the upper 
phase of the solvent composed of n-butanol, acetic acid, and water 
(4:1:5). Peptides on the paper were located by spraying with 0.2% 
n-butanol-ninhydrin and heating to color with an iron. PAUL-Y's reac-
tion 26' and chloroplatinic acid reaction 211 were also employed as specific 
reactions. 
8) Purification of Peptides by Paper Chromatography 
   Purification of peptides was performed by paper chromatography in 
the same way as above. Peptides on the paper was colored by spraying 
with 0.02% n-butanol-ninhydrin solution. The spots were cut out, 
washed out ninhydrin with acetone, eluted with 5% acetic acid for 24 
hours, and finally dried under reduced pressure. 
9) Analyses of Amino Acid compositions of Peptides 
   Peptides isolated and purified were dissolved in 5m1 of constant 
boiling point HC1 and then hydrolyzed at 110°C for 24 hours. The 
hydrolysates, after dried under reduced pressure to remove HCI, were 
subjected to an automatic amino acid analyzer (HITACHI KLA 2) for 
their amino acid compositions. Loss of amino acids during hydrolysis 
was not corrected. 
10) High Voltage Paper Electrophoresis 
   In order to discriminate asparagine from aspartic acid and glutamine 
from glutamic acid, high voltage paper electrophoresis was carried out. 
The apparatus used was Ishidai type and filter paper was Toyo Filter 
paper No. 51 (60 x 10cm). The mixture of pyridine, acetic acid, and 
water (400:1:5), pH 6.4 was, used as a buffer. The paper applied a 
peptide near the center was dried, sprayed with the buffer, and put 
in an electrophoretic tank. Electrophoresis was performed at 2 KV for 
2 hours. The peptide was detected in the same way as in the paper 
chromatography. 
11) The DNP Method for the N-Terminal Amino Acid Analyses of 
 Peptides 
   To 0.2-0.5 pmole of individual peptide dissolved in 3m1 of 1% 
NaHCO2 was added 0.05m1 of dinitrofluorobenzene (DNFB). The mixture
was allowed to react at 40°C for 2 hours. After that, the excess of 
DNFB was extracted with ether. The DNP-peptide in the aqueous 
phase was dried under reduced pressure and hydrolyzed with 4m1 of 
constant boiling point HC1 in a sealed tube at 105°C for 20 hours. The 
N-terminal amino acid was extracted with three 10ml portions of 
ether. The ether extract was transferred in a heart-shaped flask, the 
modification of MILLS' apparatus"', and dried under reduced pressure. 
The flask was connected to the cold finger and evacuated by a vacuum 
pump in order to remove as much dinitrophenol as possible. The DNP-
amino acids were identified by ascending paper chromotogrphy; The 
developer used for the first dimension was the upper phase of the 
mixture of 1N NH4 OH and n-butanol (1:1) and for the second dimen-
sion, 0.5M phosphate buffer was used. 
12) The PTC Method for Amino Acid Sequence Analyses of Peptides 
   EDMAN' S original method 111, 13) was modified here for phenylisothio-
cyanation of peptides. Trifluoroacetic acid was used for the ring-for-
mation. Analyses were performed by the elimination method"), that 
is, by comparing amino acid compositions of the original peptides with 
those of the peptides after each step of the PTC method. In 2.5m1 of 
66% pyridine contained in a heart-shaped flask, 0.5-2.0 pmoles of a 
peptide was dissolved and to this was added 0.05ml of phenylisothiocy-
anate (PTC). The solution was adjusted to pH 7.5 by adding 0.1N 
NH4 OH and then allowed to react for 3 honrs at 37°C. After that, it 
was dried under reduced pressure and evacuated for 30 minutes by a 
vacuum pump with a cold finger in order to remove the excess of PTC. 
To this was added lml of trifluoroacetic acid and it was allowed to 
stand at room temperature for 4 hours to produce the ring-formation. 
Trifluoroacetic acid was removed under reduced pressure. The residue, 
after dissolved in 3m1 of deionized water, was extracted with three 
3m1 portions of benzene. By this extraction, the PTH-amino acid was 
taken in the benzene phase and the peptide which had one N-terminal 
residue less than the original peptide was in the aqueous phase. A 
portion of the aqueous phase after dried was hydrolyzed with constant 
boiling point HC1 for 24 hours and the amino acid composition of the 
hydrolysate was analyzed. The remainder of the aqueous phase was 
subjected to the next step of the PTC method. 
              RESULTS AND DISCUSSION 
1) The Amino Acid Sequences of Chymotryptic Peptides from the ~. 
 Insoluble Tryptic Peptide (aT12, 13) 
   The insoluble tryptic peptide after oxidation was hydrolyzed with 
chymotrypsin for 4 hours and the hydrolyzed peptides were isolated and
Fig. 1 Column chromatography of the chymotryptic peptides from the oxidized in-
       soluble tryptic peptide, aT12,13 of the a-polypeptide chain in macaca mula-
      tta monkey hemoglobin
Fig. 2 Paper chromatography of the chymotryptic peptides from the oxidized insoluble 
       tryptic peptide, aT12, 13 of the a-polypeptide chain in macaca m,ulatta monkey 
      hemoglobin
purified by column chromatography (Fig. 1) and paper chromatography 
(Fig. 2). The amino acid sequences of these peptides were determined 
by the following procedure. Rf Leu values in the explanation indicate 
the relative values of the spots against leucine (-1.00) on the paper 
chromatogram. 
2) Amino Acid Sequence of Chy I-a 
   The amino acid composition of this peptide was Lys 0.99, Thr 
0.98, Ser 1.02 as shown in Table I. Its Rf Leu value was 0.08. Two 
stages of the PTC method were performed. 
 Stage 1 Thr 0.00 ; Ser 0.97 ; Lys 1.02 
 Stage 2 Thr 0.00 ; Ser 0.18 ; Lys 1.00 
Therefore, the sequence was determined to be Thr-Ser-Lys. 
3) Amino Acid Sequence of Chy V-b 
   The composition was His 0.94, Thr 0.96, Pro 0.93, Ala 1.14, and 
 Table I Amino acid compositions of the chymotryptic peptides 
            from the insoluble tryptic peptide, aT12,13 of the (j-chain 
            in macaca mulatta monkey hemoglobin
        Chy Chy Chy Chy Chy Chy Chy Chy I Chy 
         la Vb VC VId VIIa VIII VIIIb IXa Xc 
 Lys 1 0.99 0.98 1.02 
 His 0.94 0.96 0.90 0.98 
Arg 
CySO3 0.90 
Asp 0.99 1.07 
Thr 0.98 0.96 0.93 0.95 0.92 0.94 
 Ser 1.02 1.94 0.95 0.93 0.98 0.96 
Glu 1.02 
Pro 0.93 1 1.06 0.93 
Gly 
Ala 1.14 0.99 2.09 1.07 1.00 3.01 
Val 0.98 2.10 1.12 ' 1.02 0.95 1.08 
Met ' 
Leu 2.08 1.98 1.11 1.05 1.08 1.05 5.25 
Tyr 
Phe 0.91 0.95 0.93 
Try
Val 0.98 as shown in Table I, and the Rf value was 0.32. Four stages 
of the PTC method were performed. 
 Stage 1 His+Thr 0.00 Pro 0.93 Ala 1.05 Val 0.98 
 Stage 2 His+Thr 0.00 Pro 0.20 Ala 1.06 Val 0.94 
 Stage 3 His +Thr 0.00 Pro 0.12 Ala 0.22 Val 0.96
 Stage 4 His 1.00 Thr 0.00 Pro 0.00 Ala 0.11 Val 0.25 
As the result, the sequence was Thr-Pro-Ala-Val-His. 
4) Amino Acid Sequence of Chy V-c 
   As shown in Table I this peptide consisted of eight amino acid 
residues such as Thr 0.93, Ser 1.94, Ala 0.99, V al 2.10, and Leu 
2.08. The Rf Leu value was 1.17. The N-terminal residue of this 
peptide was known to be leucine by the DNP method. This peptide 
was further hydrolyzed with pepsin at 37°C for 3 hours and subjected 
to paper chromatography for isolation and purification. Two peptides 
were obtained. 
a) Chy V-c pep I 
   The amino acid composition was Thr 0.98, Val 0.94, and Leu 1.06. 
The Rf Leu value was 1.14. Two stages of the PTC method were 
carried out. 
 Stage 1 Thr 0.00 Val 0.98 Leu 1.02 
 Stage 2 Thr 0.00 Val 0.20 Leu 1.00 
The sequence was, therefore, Thr-Val-Leu. 
b) Chy V-c pep II 
   The other peptic peptide was composed of Leu 1.03, Ala 1.06, Ser 
1.95, and Val 0.96. The Rf Leu value was 0.80. Four stages of the 
PTC method were performed. 
 Stage 1 Leu 0.00 Ala 1.02 Ser 1.98 Val 1.00 
 Stage 2 Leu 0.00 Ala 0.12 Ser 2.01 Val 0.98 
 Stage 3 Leu 0.00 Ala 0.00 Ser 0.99 Val 1.00 
 Stage 4 Leu 0.00 Ala 0.00 Ser 1.00 Val 0.21 
As the result, the sequence was determined to be Leu-Ala-Ser-Val-Ser. 
Since the N-terminal residue had been known to be leucirie, the se-
quence of Chy V-c was determined as follows; 
    Leu-Ala-Ser-Val-Ser-Thr-Val-Leu. 
5) Amino Acid Sequence of Chy VI-d 
   The amino acid composition of this peptide was Thr 0.95, Val 
1.12, and, 1.98. The Rf Leu value was 1.29. Three stages of the 
PTC method were carried out. 
 Stage 1 Leu 0.99 Val 1.00 Thr 0.99 
 Stage 2 Leu 1.00 Val 0.20 Thr 0.98 
 Stage 3 Leu 1.00 Val 0.15 Thr 0.23 
The sequence was Leu-Val-Thr-Leu. 
6) Amino Acid Sequence of Chy VII-a and Chy VIII-b 
   The amino acid composition of Chy VII-a is as follows; Lys 0.98, 
His 0.96, Asp 0.99, Thr 0.92, Ser 0.95, Pro 1.06, Ala 2.09, Val 1.02, 
Leu 1.11, Phe 0.91. The Rf Leu value was 0.34. The N-terminal 
residue was known to be threonine by the DNP method. It appeared 
from the amino acid composition that Chy VII-a was the combination
of Chy V-b and Chy VIII-b, being the former at the N-terminal side. Now, 
the sequence of Chy VIII-b had to be determined. The composition of 
Chy VIII-b was Ser 0.98, Ala 1.00, Lys 1.02, Asp 1.07, Leu 1.08, and 
Phe 0.95. The Rf Leu value was 0.73. Five stages of the PTC method 
were carried out. 
  Stage 1 Ala 0.00 Ser 0.96 Leu 1.04 Asp 1.07 Lys+Phe 0.96 
  Stage 2 Ala 0.00 Ser 0.08 Leu 1.02 Asp 1.04 Lys +Phe 0.94 
  Stage 3 Ala 0.00 Ser 0.00 Leu 0.15 Asp 1.02 Lys +phe 1.00 
  Stage 4 Ala 0.00 Ser 0.00 Leu 0.11 Asp 0.23 Lys 1.02 Phe 1.00 
  Stage 5 Ala 0.00 Ser 0.00 Leu 0.09 Asp 0.10 Lys 0.29 Phe 1.00 
According to the above result, the sequence of Chy VIII-b was Ala-
Ser-Leu-Asp-Lys-Phe. The result from the high voltage paper electro-
phoresis showed the residue presented as Asp in this sequence was 
aspartic acid. 
The sequence of Chy VII-a was, therefore, Thr-Pro-Ala-Val-His-Ala-Ser-
Leu-Asp-Lys-Phe. 
7) Amino Acid Sequence of Chy IX-a 
   The amino acid composition of this peptide was as follows; His 
0.90, Glu 1.02, Pro 0.93, Ala 3.01, Leu 1.05, Phe 0.93. The Rf Leu 
value was 0.60. Four stages of the PTC method were first carried out. 
  Stage 1 Ala 1.97 His +Leu 1.03 Pro 1.00 Glu 0.98 Phe 0.98 
 Stage 2 Ala 1.01 His 0.98 Leu 1.02 Pro 0.98 Glu 1.03 Phe 0.97 
  Stage 3 Ala 1.00 His 0.21 Leu 0.99 Pro 0.97 Glu 1.04 Phe 0.96 
 Stage 4 Ala 1.01 His 0.00 Leu 0.30 Pro 0.98 GI u 1.02 Phe 0.98 
After the fourth stage, the remaining peptide was purified by paper 
chromatography. This purified peptide was composed of Pro 0.98, Ala 
1.02, Glu 1.05, and Phe 0.95. The Rf Leu value was 0.83. Three 
stages of the PTC method were further performed. 
 Stage 1 Pro 0.00 Ala 1.04 Glu 1.02 Phe 0.94 
 Stage 2 Pro 0.00 Ala 0.12 Glu 1.05 Phe 0.95 
 Stage 3 Pro 0.00 Ala 0.08 Glu 0.20 Phe 1.00 
The sequence of Chy IX-a was, therefore, Ala-Ala-His-Leu-Pro-Ala-
Glu-Phe. The result from the high voltage paper electrophoresis showed 
that the residue presented as Glu in the sequence was glutamic acid. 
8) Amino Acid Sequence of Chy X-c 
   The amino acid composition of this peptide was as follows; His 
0.98, CysSo3 0.90, Thr 0.90, Ser 0.96, Val 1.08, and Leu 5.25. The 
Rf .Leu value was 0.93. Six stages of the PTC method were carried 
out. 
 Stage 1 His (+) Cys (+) Thr 0.94 Ser 0.98 Val 1.00 Leu 4.04 
 Stage 2 His (+) Cys (+) Thr 0.96 Ser 0.96 Val 0.95 Leu 3.12 
 Stage 3 His 0.98 Cys (+) Thr 0.98 Ser 0.12 Val 0.94 Leu 3.10 
 Stage 4 His 0.18 Cys (-F) Thr 0,98 Ser 0.09 Val 0' 98 Leu 3.11
Fig. 3 Column chromatography of rehydrolyzed products with trypsin of the oxidized 
       peptide, aT12,13 in macaca mulatta monkey hemoglobin
                                          Fraction niininber 
Fig. 4 Paper chromatography of rehydrolyzed products with trypsin of the oxidized 
       DeDtide. aT12.13 in mctcaca mulatta monkey hemogloin
 Stage 5 His 0.11 Cys (-) Thr 0.99 Ser 0.02 Val 0.98 Leu 3.04 
 Stage 6 His 0.12 Cys (-) Thr 0.99 Ser 0.03 Val 0.95 Leu 2.06 
The above-described result showed that the remaining peptide which 
was composed of the four amino acid was Chy VI-d. The sequence of 
Chy X-c was determined as follows;
As described above, the amino acid sequences of the chymotryptic 
peptides from the insoluble tryptic peptide (aT12, 13) were determined. 
   Next, in order to determine the peptide sequence of these chymo-
tryptic peptides, 100mg of the insoluble tryptic peptide (aTl2, 13) was 
rehydrolyzed with trypsin at 0°C for 7 hours in 1N NH, OH. The hy-
drolysate was isolated by the Dowex 1 x 2 column chromatography (Fig. 
3) and purified by the paper chromatogrpahy (Fig. 4). Consequently, 
the amino acid compositions and the N-terminal residues of the two 
spots, TTI-a and TTVI-c were examined. 
Analysis of TTI-a 
   The amino acid composition of this peptide was as follows; Lys 
1.12, Thr 1.96, Ser 2.93, Ala 1.06, Val 1.92, Leu 2.01, Phe 0.92. The 
Rf Leu. value was 0.71. The N-terminal residue was phenylalanine. 
   By considering these results together with those on the chymotry-
ptic peptides from the insoluble tryptic peptide (aT12, 13), this TTI-a 
appeared to be the combination of Chy I-a and Chy V-c plus one residue 
of phenylalanine. Accordingly, since the N-terminal residue of TTI-a 
had been known to be phenylalanine and the C-terminal residue was 
considered to be lysine because it was the tryptic hydrolysate, the 
amino acid sequence of TTI-a was determined as follows;
Analysis of TTVI -C 
   The amino acid composition of this peptide was as follows; Lys 
1.02, His 2.93, Cys 0.90, Asp 1.02, Thr 1.94, Ser 1.92, Glu 1.10, Pro 
2.01, Ala 5.11, Val 1.86, Leu 7.25, Phe 0.92. 
The Rf Leu value was 0.71. The N-terminal amino acid residue was 
confirmed to be leucine by the DNP method. By considering the results 
on the chymotryptic peptides from the insoluble tryptic peptide (aT12,
13), this peptide agreed with the combination of Chy X-c, Chy IX-a, 
and. Chy VII-a minus one residue of phenylalanine. Because this waE 
a tryptic hydrolysate, the C-terminal residue was considered to be 
lysine. Therefore, the sequence of TTVI-c was determined as follows;
   The N-terminal residue of the insoluble tryptic peptide (aT12, 13) 
had been known to be leucine, TTVI-c was considered to be located at 
the N-terminal side and TTI-a at the C-terminal side, that is, TTVI-c 
accorded with aT12 and TTI-a, with aT13. 
   Accordingly, the amino acid sequence of the insoluble trptic pe-
ptide (aT12,13) was determined as illustrated in Fig. 5.
Fig. 5 Amino acid sequence in the oxidized insoluble tryptic peptide, aT12,13 
         of the a-polypeptide chain in macaca mulatta monkey hemoglobin. 
                CONCLUSION 
The amino acid composition and the sequence of the insoluble try.
ptic peptide (aT12,13) in the a-polypeptide chain from macaca mulatta 
monkey hemoglobin were determined. The results were compared with 
the known composition and sequence of human hemoglobin. Both hemo-
globins are quite similar as to this region. 
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